"I like building teams to solve hard problems."
I joined Genentech in June of 2005 as Vice President, Small Molecule Drug Discovery. In 2010 I was named Senior Vice President, Research and Small Molecules, and I am currently Executive Vice President, Genentech Research and Early Development. In this role, I am responsible for the management of all aspects of our drug discovery and drug development activities. In addition, I am a member of the Genentech Executive Committee and a member of the expanded Corporate Executive Committee for Roche.
I was attracted to Genentech because of my long-standing interest in translating excellent science into therapies to treat unmet medical needs. I continue to be excited by the prospect of utilizing Genentech's deep expertise in biology to discover and develop novel and innovative drug molecules of all types to contribute to the health and well being of our community. I like the idea of building large diverse teams of highly skilled scientists who work together to solve very difficult problems.
Proc Am Assoc Cancer Res 40(90); 291-92
My current focus is to ensure that the quality of science within Genentech is as high as possible and that our approaches to problem solving use the most up-to-date tools and technologies. Fostering innovation and ensuring that science drives decision-making are key leadership focus areas. We are a team-based organization where everyone’s contributions are valued. Drugs come from project teams; facilitating cross-functional project teams is our central focus.